Latest 8-K filings

Cypherpunk Technologies announced its second quarter 2026 financial results, highlighting an increase in Zcash holdings and progress for its subsidiary Leap Therapeutics' cancer drug candidate, sirexatamab.

Cycurion, Inc. confirms its Nasdaq hearing is scheduled for August 20, 2026, with its common stock continuing to trade on the Nasdaq Capital Market.

Fervo Energy announced strong operational progress in Q2 2026, including advancements in its Cape Station project and a successful $2.2 billion IPO, while reporting an operating loss of $28.7 million.

Humacyte announced positive Q2 2026 results, highlighting breakthrough Phase 3 data for its dialysis access product and progress in its coronary artery bypass graft program.

Lexeo Therapeutics announced key business highlights and financial results for Q2 2026, including the initiation of a pivotal trial for LX2006 and FDA RMAT designation for LX2020, with cash runway extending into 2028.

Acumen Pharmaceuticals announced its second quarter 2026 financial results and provided a business update, including expected topline results for its Phase 2 ALTITUDE-AD study in late 2026 and progress on its Enhanced Brain Delivery program.

Octave Intelligence plc announced its second quarter 2026 financial results, reporting a significant net loss due to impairment charges, though recurring revenue and annualized recurring revenue (ARR) showed growth.

Trimble Inc. announced robust second quarter 2026 results, highlighted by record annualized recurring revenue and raised full-year financial guidance, alongside a new $1.0 billion share repurchase authorization.

Bausch + Lomb Corporation announces amendments to its prior 8-K filing, detailing significant shifts in Board leadership and committee appointments effective August 5th and August 10th, 2026.

Sound Point Meridian Capital announced fee adjustments for the latter half of 2026 and declared distributions for its common and preferred stock, alongside first quarter 2026 financial results.

Performance Food Group Company announced robust fourth-quarter and full-year fiscal 2026 results, highlighted by significant case volume growth, increased net sales, and improved profitability, alongside providing positive financial guidance for fiscal year 2027.

Protalix BioTherapeutics announces significant revenue growth and profitability for Q2 2026, driven by Elfabrio sales and a milestone payment, while advancing its PRX-115 clinical trial.

Kontoor Brands reported a 19% revenue increase in Q2 2026, driven by Helly Hansen and Wrangler, and raised its full-year EPS outlook.

T1 Energy announced its second quarter 2026 financial results, reporting $250.1 million in net sales and $10.7 million in Adjusted EBITDA, while also detailing strategic acquisitions and progress on its G2_Austin solar fab.

Liquidia Corporation announced robust second quarter 2026 financial results, highlighted by a 31% sequential increase in YUTREPIA net product sales to $170.4 million and a fourth consecutive quarter of increasing profitability.

Nova Minerals Corp provides a comprehensive update on its 2026 field season at the Estelle Gold and Critical Minerals Project, highlighting operational progress, drilling results, and permitting advancements.

Bio-Techne Corporation announced its fourth quarter and full year fiscal 2026 results, highlighting a 3% organic revenue increase in Q4 and confirming its acquisition by Merck KGaA for $73 per share.

Annexon, Inc. announced second quarter 2026 financial results, business updates including expansion of its Vonaprument Phase 3 program for geographic atrophy, and a $200 million credit facility.

Greenland Energy Company announced a delay in its Greenland permitting process, now targeting winter 2027 for permit approval due to a more extensive review.

Amcor plc announced robust fourth quarter and full-year financial results for fiscal year 2026, showcasing substantial revenue growth and improved profitability following the acquisition of Berry Global.

Eagle Point Income Company Inc. announced its upcoming conversion to a Delaware Statutory Trust, effective August 24, 2026, and a name change to Eagle Point Income Company.

BETA Technologies announced robust second-quarter 2026 financial and operating results, showcasing significant revenue growth and key advancements in its aerospace platform, including new aircraft unveilings and successful flight demonstrations.

National Vision Holdings announced robust second quarter 2026 financial results, showcasing accelerated profitability and an improved outlook for the full fiscal year.

American Strategic Investment Co. reported a significant decrease in revenue and a net loss for the second quarter of 2026, though Adjusted EBITDA showed improvement.

Artificial Intelligence Technology Solutions' subsidiary, RAD, announced a second order for three ROSA security units from a national dealer within days of the initial order, signaling rapid momentum.

Blue Owl Capital Inc. announced the pricing of its $750 million offering of 6.750% Senior Notes due 2036, aimed at repaying outstanding borrowings.

Realty Income Corporation successfully priced an upsized $875 million offering of 3.750% convertible senior notes due 2031 to qualified institutional buyers.

Hashdex announced plans to close and liquidate the Hashdex Bitcoin ETF (DEFI), with trading to cease on August 17, 2026, and distributions expected around August 24, 2026.

Eagle Point Credit Company announced its unaudited estimated Net Asset Value (NAV) per common share for July 31, 2026, ranging between $4.33 and $4.43.

Inuvo, Inc. announced its second quarter 2026 financial results, highlighting a 19% revenue growth in Audience Modeling, while also detailing a significant strategic pivot and leadership transitions including the retirement of its CFO.